Table 1.
Key subject characteristics and parameters.
Age group | 20–29 | 30–39 | 40–49 | 50–59 | 60–69 | 70–79 |
---|---|---|---|---|---|---|
Age (years)⁎ | 26.9 ± 2.3 | 33.9 ± 2.8 | 44.8 ± 3.2 | 54.9 ± 3 | 63.1 ± 2.6 | 74.3 ± 2.2 |
Female/male (N) | 11/5 | 9/7 | 9/7 | 10/6 | 7/9 | 9/7 |
Weight (kgs) | 76.1 ± 16.5 | 75.1 ± 12 | 78.8 ± 9.2 | 76.3 ± 15.6 | 74.4 ± 18.7 | 68.5 ± 13.6 |
Height (cms) | 170.8 ± 8.4 | 172.2 ± 9.6 | 174.6 ± 11.8 | 172.4 ± 9 | 170.4 ± 10.4 | 164.4 ± 10.1 |
BMI (kg/m2) | 26.1 ± 5.8 | 25.3 ± 2.9 | 26 ± 3.4 | 25.6 ± 4 | 25.3 ± 4.4 | 25.2 ± 2.6 |
Body surface area (m2) | 1.8 ± 0.2 | 1.8 ± 0.2 | 1.8 ± 0.2 | 1.8 ± 0.2 | 1.8 ± 0.2 | 1.7 ± 0.2 |
Heart rate (beats/min) | 59.4 ± 7.7 | 59.6 ± 8 | 58.8 ± 7.7 | 60.2 ± 10.2 | 56.4 ± 9.7 | 61.4 ± 11.5 |
Cholesterol (mmol/l)⁎ | 4.6 ± 0.9 | 4.5 ± 0.8 | 4.7 ± 0.9 | 4.8 ± 0.7 | 4.8 ± 0.6 | 5.3 ± 1.1 |
Triglycerides (mmol/l) | 0.93 ± 0.45 | 0.95 ± 0.61 | 0.9 ± 0.34 | 0.86 ± 0.64 | 1.02 ± 0.47 | 1.07 ± 0.38 |
HDL (mmol/l) | 1.5 ± 0.4 | 1.7 ± 0.3 | 1.5 ± 0.4 | 1.8 ± 0.6 | 1.6 ± 0.5 | 1.6 ± 0.4 |
LDL (mmol/l)⁎ | 2.6 ± 0.8 | 2.4 ± 0.7 | 2.8 ± 0.7 | 2.7 ± 0.7 | 2.8 ± 0.5 | 3.2 ± 0.9 |
Systolic pressure (mm Hg)⁎ | 120.4 ± 10.5 | 127.4 ± 10.2 | 124.0 ± 9.0 | 124.4 ± 7.4 | 127.1 ± 14.8 | 136.7 ± 10.8 |
Diastolic pressure(mm Hg) | 64.9 ± 6.9 | 71.3 ± 8 | 68.1 ± 6.8 | 69.1 ± 9.2 | 68.3 ± 7.6 | 71.8 ± 7.8 |
Pulse pressure (mm Hg)⁎ | 55.4 ± 5.9 | 55 ± 5.3 | 55.9 ± 5 | 55.3 ± 7.4 | 58.8 ± 10.3 | 64.9 ± 7.5 |
Mean arterial pressure (mm Hg)⁎ | 87.1 ± 8.2 | 93.5 ± 7.7 | 91.9 ± 8.5 | 93 ± 8.1 | 93.1 ± 10.4 | 99.3 ± 10.2 |
Aortic systolic pressure (mm Hg)⁎ | 113.7 ± 9.3 | 120.2 ± 8.5 | 121.1 ± 8.6 | 122 ± 7.9 | 124.7 ± 14.3 | 134.7 ± 11.1 |
Aortic pulse pressure (mm Hg)⁎ | 49.4 ± 4.7 | 49.9 ± 6.5 | 53.1 ± 4.7 | 52.9 ± 7.7 | 56.4 ± 9.9 | 62.9 ± 7.9 |
BMI: body mass index, HDL: high density lipoprotein, LDL: low density lipoprotein.
ANOVA significance p < 0.05.